Scilex Holding - SCLX Accounting Value per Share

SCLX (Scilex Holding Company) - company brandmark

Scilex Holding Company (SCLX) is a biopharmaceutical player developing non-opioid pain management solutions. Protected patents and consistent demand ensure high margins and a stable cash flow, which currently stands at -43.97. This price chart on GURU.Markets complements revenue data from the sale of innovative sprays and patches. The company's environmental policy focuses on proper waste disposal and the gradual reduction of its carbon footprint.

SCLX Scilex Holding Equity per Share (04/28/2023 - 10/31/2026)

Summary analytical data breakdowns for scilexholding.com (SCLX)

- current quotes and average value forecast:
Price Chart Scilex Holding Co.|SCLX - Price Target Chart
- issuer market value details:
Market Valuation Scilex|SCLX - Business Value
- balance sheet net asset value indicators:
Net Assets per Single Share Scilex Holding Company|SCLX - Accounting Capitalization|Market Capitalization to Book Value Ratio scilexholding.com|SCLX - Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Scilex Holding Company|SCLX - Long-Term Debt to Capital|Short-Term Debt to Equity Scilex|SCLX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Scilex|SCLX - Long-Term Debt|Company Short-Term Debt Scilex Holding Company|Quick Ratio scilexholding.com
- earnings and multiples data:
SCLX - Net Income
General company analysis:SCLX - Scilex Holding Co.
Flagship merchandise of Scilex

For Scilex Holding Company (SCLX), with its scalable distribution network for analgesic patches, the reported book value per share serves as an indicator of net asset capitalization. This metric is calculated as the difference between total assets and liabilities divided by the number of shares outstanding, allowing investors to determine the business's intrinsic value and assess the margin of safety during market corrections.

Main competitors

BIIB - Net Assets per Single Share|NBIX: Net Assets per Single Share|RGC (Regencell Bioscience) - Accounting Value per Share|Equity per Share AXSM|Net Assets per Single Share ACADIA Pharmaceuticals Inc.|Equity per Share XENE (Xenon Pharmaceuticals Inc.)|Book Value per Share VKTX|SUPN - Net Asset Value per Share|Catalyst Pharmaceuticals - Accounting Value per Share|Book Value per Share denalitherapeutics.com DNLI|HRMY - Net Assets per Single Share|Accounting Value of a Share BHVN (Biohaven Ltd)|Amylyx (AMLX) - Net Assets per Single Share|Net Asset Value per Share Trevi Corp (TRVI)|Net Assets per Single Share Praxis Precision Medicines|anavex.com (AVXL) - Net Assets per Share|Book Value per Share CBLL|Accounting Value per Share Prothena Corporation PRTA|Book Value per Share ALEC (Alector)|Net Assets per Share Annexon Biosciences Inc. (ANNX)|OMER - Net Assets per Single Share|NGNE: Net Assets per Single Share|ACIU: Book Value per Share|Net Asset Value per Share Voyager Therapeutics Inc (VYGR)|Accounting Value per Share NMRA|Equity per Share TVGN (Tevogen Bio Inc.)|Accounting Value per Share ACOG (Alpha Cognition)|CGTX (Cognition Therapeutics Inc.) - Accounting Value of a Share|Book Value per Share IKT (Inhibikase Therapeutics, Inc.)|Accounting Value of a Share SAVA|ASRT - Net Assets per Single Share|Net Asset Value per Share Coya Therapeutics, Inc.|vistagen.com (VTGN) - Net Assets per Single Share|OVID (Ovid Therapeutics) - Net Assets per Single Share|ABOS (Acumen Pharmaceuticals, Inc.) - Book Value per Share|Equity per Share CRVO (CervoMed, Inc.)|Book Value per Share ATHE|Net Assets per Share clene.com|Net Assets per Single Share PepGen PEPG|JUNS: Equity per Share|Relmada Therapeutics, Inc. - Book Value per Share|Book Value of One Share Annovis Bio Inc (ANVS)|GRCE (gracetx.com) - Accounting Value per Share|Firefly Neuro - Accounting Value of a Share|KLTO (ANEW Medical) - Book Value per Share|Accounting Value per Share NeuroSense Therapeutics, Ltd. (NRSN)|Net Assets per Single Share Reviva Pharmaceuticals Holdings, Inc. (RVPH)|MTVA - Net Asset Value per Share|Net Assets per Single Share NeurAxis, Inc NRXS|HSDT - Accounting Value per Share|PASG - Net Assets per Single Share|Share Book Value NEUP|NERV: Book Value per Share|Athira Pharma Inc (ATHA) - Book Value per Share|Net Assets per Single Share Addex Therapeutics, Ltd.|Equity per Share ALZN (Alzamend)|Accounting Value per Share CYCN (Cyclerion Therapeutics)|PTIX - Net Asset Value per Share|Net Assets per Single Share Pasithea Therapeutics Corp. KTTA|Net Assets per Share Cortigent Inc (CRGT)|Avenue Therapeutics, Inc - Book Value per Share|BrainStorm Cell Therapeutics Inc. (BCLI) - Accounting Value per Share|Cara Therapeutics, Inc. (CARA) - Net Assets per Single Share|CHRO (chromocell.com) - Net Assets per Single Share|Accounting Value per Share ELYM|Equity per Share ITCI (Intra-Cellular)|Net Assets per Single Share Longboard Pharma (LBPH)|Marinus Pharma - Equity per Share|Book Value per Share NKGN (NKGen Biotech, Inc.)|neurobopharma.com (NRBO) - Net Asset Value per Share|SAGE: Accounting Value per Share|SNPX - Book Value per Share|Trevena, Inc (TRVN) - Net Assets per Single Share|Vigil Neuroscience, Inc. - Accounting Value of a Share|Net Assets per Single Share Anew Medical|Net Asset Value per Share cerevel.com CERE